Abbott Biotech Ventures Backs NeuroGenetic

San Diego-based NeuroGenetic Pharmaceuticals has raised an undisclosed amount from Abbott Biotech Ventures. The company is focused on developing Alzheimer’s disease therapeutics.

ByVCJ Staff

4 January 2012•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

North America US Briefs

Abbott Biotech Ventures Backs NeuroGenetic

NGP